VEGFA and non-small cell lung carcinoma: Bevacizumab is a humanised Moab targeting VEGF, which has shown clinical activity in combination with cytotoxic chemotherapy in metastatic colorectal cancer, non-small cell lung cancer (NSCLC) and breast cancer (Hurwitz et al, 2004; Ramaswamy et al, 2006; Sandler et al, 2006).